Note: Quarterly earnings detail and consensus estimates not available in current data feed. Analysis based on available YoY growth rates.
| Metric | Value | Assessment |
|---|---|---|
| EPS TTM | $49.36 | Strong absolute profitability |
| EPS Growth YoY | +21.39% | Double-digit earnings expansion |
| Revenue Growth YoY | +24.33% | Topline acceleration outpacing earnings |
| Forward P/E | 13.90x | Implies forward EPS ~$2.69 (growing) |
| Growth Profile | Hyper-Growth | Flagged as high-growth candidate |
Strong YoY earnings (+21%) and revenue (+24%) growth. EPS expansion outpacing revenue suggests operational leverage. Hyper-growth flag indicates market confidence. Limited visibility into quarterly trends and guidance due to data constraints, but momentum remains solidly positive.
Detailed margin data (gross, operating, net) and FCF metrics not available in current data feed. Analysis relies on EPS quality and sector-level inferences.
| Metric | Value | Interpretation |
|---|---|---|
| EPS (TTM) | $49.36 | High absolute earnings per share relative to price |
| P/E Ratio | 16.74x | Moderate valuation for insurance sector |
| PEG Ratio | 0.783 | Attractive — PEG < 1.0 indicates growth priced competitively |
| Strong Profitability Flag | Not flagged | Quality score moderate; margin data constrained |
| Sector | Insurance | Capital-intensive; focus on underwriting discipline and investment returns |
EPS quality appears solid with 21% YoY growth and PEG < 1.0 suggesting healthy growth-adjusted valuation. However, profitability margins (gross, operating, net) and return metrics (ROE, ROIC) not disclosed. Insurance sector typically operates on moderate net margins (3–8%) with earnings driven by underwriting and investment portfolio performance. Strong profitability flag not triggered, indicating below-sector-average margins. Recommend verification of underwriting profit ratios and combined ratios.
Detailed balance sheet (cash, debt, equity structure) not available in current data feed. Risk flag analysis based on available indicators.
| Metric | Value | Risk Assessment |
|---|---|---|
| Weak Balance Sheet Flag | Not flagged | System does not detect elevated balance sheet risk |
| Beta | 0.771 | Low volatility — defensive characteristics; lower systematic risk than market |
| Market Cap | $93.9B | Large-cap institutional-grade insurer; strong market position |
| Dividend Per Share | $32.79 | High absolute dividend suggests capital return capacity and financial strength |
| Data Gaps | Earnings, Profile2 | Limited visibility into detailed balance sheet and capital structure |
No weak balance sheet flag triggered. Low beta (0.77) and $32.79 dividend payout signal financial stability and capital management discipline. Large-cap market position ($93.9B) suggests institutional-grade credit quality. Detailed cash, debt, and leverage ratios not available; however, insurance sector peer comparables and absence of distress signals imply adequate capitalization. Recommend verification of solvency ratios and reserve adequacy through regulatory filings.
| Multiple | ZURVY | Assessment |
|---|---|---|
| Trailing P/E | 16.74x | Moderate; insurance sector median typically 12–18x |
| Forward P/E | 13.90x | Attractive — discount to trailing suggests earnings growth ahead |
| PEG Ratio | 0.783 | Compelling — value play for growth; < 1.0 = undervalued relative to growth |
| High Valuation Flag | Not flagged | Multiples do not suggest expensive positioning |
| Price-to-Sales / EV | Limited visibility | Revenue metrics not fully disclosed; EV approximated at market cap |
Trading at 16.7x trailing P/E and 13.9x forward P/E, consistent with insurance peer ranges. PEG ratio of 0.78 is highly attractive, indicating the market is undervaluing earnings growth relative to sector norms. Forward P/E discount to trailing P/E implies positive earnings momentum priced in. Risk flag for high valuation is not triggered. Overall, valuation provides a reasonable margin of safety for growth-oriented insurance investor.
Analyst consensus targets and ratings not available in current data feed.
| Metric | Value | Interpretation |
|---|---|---|
| Consensus Target Price | Not disclosed | Coverage constrained; recommend checking institutional platforms |
| Analyst Rating | Not disclosed | Data gap — analyst consensus not available |
| Implied Upside / Downside | Unable to calculate | Requires consensus target; current price $37.36 |
| Earnings Estimate Dispersion | Not disclosed | Confidence in earnings forecasts unknown |
| Sector Context | Insurance | Insurance stocks typically benefit from rate environment tailwinds; monitor policy renewal trends |
Analyst consensus targets and ratings not available in current feed. Unable to assess formal Wall Street positioning or rating distribution. Historical 52-week return of +9.37% suggests modest market favor. Recommend supplementing analysis with real-time consensus from Bloomberg Terminal, FactSet, or broker platforms for definitive sentiment assessment.
Institutional ownership, insider activity, and short interest data not available in current feed.
| Risk Factor | Status | Commentary |
|---|---|---|
| Institutional Ownership | Not disclosed | Data gap; typical for large-cap Swiss insurers: 40–70% institutional |
| Insider Trading Activity | Not disclosed | No insider transaction data available |
| Short Interest | Not disclosed | Short float not available; recommend checking stock lending markets |
| Weak Balance Sheet Flag | Not triggered | No systemic balance sheet distress detected |
| Regulatory / ESG Risk | Insurance sector standard | Subject to solvency, reserve, and climate risk oversight |
| Sector Cyclicality | Moderate | Insurance earnings sensitive to catastrophe frequency, investment returns, interest rates |
No balance sheet distress signals. Large-cap positioning ($93.9B) and low beta (0.77) suggest institutional-grade credit and lower volatility. Key risks: (1) limited visibility into institutional ownership concentration, (2) insurance sector cyclicality (underwriting cycles, catastrophe exposure), (3) investment portfolio sensitivity to interest rate and equity market movements, (4) regulatory capital requirements. Recommend ongoing monitoring of combined ratios, reserve adequacy, and asset quality through earnings releases and regulatory filings.
Supported by strong EPS (21% YoY) and revenue growth (24% YoY), attractive PEG (0.78), and low balance sheet risk. Conviction moderated by constrained data visibility (earnings detail, margin composition, analyst consensus).
- Growth + Value Hybrid: 21% EPS YoY and 24% revenue YoY growth paired with reasonable valuation (PEG 0.78) creates attractive risk-reward for medium-term holding.
- Balance Sheet Stability: Low beta (0.77), absence of distress signals, and $32.79 dividend underscore defensive positioning within insurance sector.
- Valuation Upside: Forward P/E (13.9x) discount to trailing (16.7x) implies market confidence in earnings momentum; further re-rating possible if growth sustains.
- Data Constraints: Limited visibility into quarterly earnings beats, margin trends, analyst consensus, and institutional positioning. Recommend supplementing with earnings transcripts, broker notes, and regulatory filings.
- Sector Tailwinds: Insurance cycle positioning and potential rate environment benefits support 6–12 month outlook; monitor underwriting discipline and catastrophe exposure.
ZURVY Stock Analysis & Forecast
Is ZURVY a Good Investment in 2026?
Our model indicates a neutral outlook based on current fundamentals and momentum.
ZURVY Stock Forecast
Based on recent earnings trends, valuation metrics, and sector performance, ZURVY shows balanced risk-reward characteristics.
Should You Buy ZURVY Now?
Investors should consider market conditions, volatility, and long-term positioning before taking a position in ZURVY.